<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03901937</url>
  </required_header>
  <id_info>
    <org_study_id>SRRSH20180925-8</org_study_id>
    <nct_id>NCT03901937</nct_id>
  </id_info>
  <brief_title>The Effects of Parenteral ω-3 Polyunsaturated Fatty Acid on Postoperative Complications of Patients With Crohn's Disease</brief_title>
  <acronym>ω3CD</acronym>
  <official_title>Department of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310016, China</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sir Run Run Shaw Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sir Run Run Shaw Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is intended to investigate the safety and efficacy of ω-3 polyunsaturated fatty
      acid-based parenteral nutrition (PN) for patients with Crohn's disease.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2019</start_date>
  <completion_date type="Anticipated">March 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of Postoperative complications</measure>
    <time_frame>postoperative 1-30 days</time_frame>
    <description>postoperative complications after surgery for Crohn's Disease according to clavien-dindo system</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Length of postoperative hospital stay</measure>
    <time_frame>from surgery to discharge</time_frame>
    <description>postoperative hospital stay after surgery for Crohn's Disease</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Concentration of IL-6</measure>
    <time_frame>postoperative 1, 3, and 6 day</time_frame>
    <description>Blood Concentration of IL-6 after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Concentration of TNF-α</measure>
    <time_frame>postoperative 1, 3, and 6 day</time_frame>
    <description>Blood Concentration of TNF-α after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Concentration of IL-1β</measure>
    <time_frame>postoperative 1, 3, and 6 day</time_frame>
    <description>Blood Concentration of IL-1β after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Concentration of albumin</measure>
    <time_frame>postoperative 1, 3, and 6 day</time_frame>
    <description>Blood Concentration of albumin after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Concentration of C-reactive protein</measure>
    <time_frame>postoperative 1, 3, and 6 day</time_frame>
    <description>Blood Concentration of C-reactive protein after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood White blood cell level</measure>
    <time_frame>postoperative 1, 3, and 6 day</time_frame>
    <description>Blood White blood cell level after surgery</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">158</enrollment>
  <condition>Crohn Disease</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>parenteral nutrition without ω-3 polyunsaturated fatty acid</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ω-3 fatty acid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>parenteral nutrition with ω-3 polyunsaturated fatty acid</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ω-3 polyunsaturated fatty acid</intervention_name>
    <description>CD patients are divided into two groups, which include with and without ω-3 polyunsaturated fatty acid-based PN (0.1-0.2g/kg/d).</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Omegaven®10%</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Intestinal surgery for Crohn's Disease</intervention_name>
    <description>Patients receive bowel resection due to complications of Crohn's Disease</description>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_label>ω-3 fatty acid</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Diagnosis as Crohn's disease according to definition;

          2. Bowel resection;

          3. With parenteral nutrition at least 5 days

          4. 18 years old&lt;age&lt;75 years old;

          5. Sign the informed consent.

        Exclusion Criteria:

          1. Emergency surgery;

          2. With severe comorbidity and/or organ (kidney,liver,or heart) dysfunction;

          3. Incomplete laboratory data;

          4. With parenteral nutrition before surgery;

          5. Pregnant;

          6. Allergy of ω-3 polyunsaturated fatty acid.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xiujun Cai</last_name>
    <role>Study Chair</role>
    <affiliation>Sir Run Run Shaw Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wei Zhou, MD PHD</last_name>
    <phone>13588706479</phone>
    <email>zhouw@srrsh.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sir Run Run Shaw hospital</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>310016</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaolong Ge, PhD</last_name>
      <phone>13867106984</phone>
      <email>gxlnjumed09@126.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>March 12, 2019</study_first_submitted>
  <study_first_submitted_qc>April 2, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 3, 2019</study_first_posted>
  <last_update_submitted>April 2, 2019</last_update_submitted>
  <last_update_submitted_qc>April 2, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 3, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sir Run Run Shaw Hospital</investigator_affiliation>
    <investigator_full_name>Wei Zhou</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>postoperative complications</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Crohn Disease</mesh_term>
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Data collection from 2019-3 to 2020-9</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

